Combinations Alliance

The Combinations Alliance utilises the expertise from the translational groups within the Experimental Cancer Medicine Centres (ECMC) network, to drive academic - industrial partnership, generating novel treatment options for people with cancer that would otherwise unlikely be realised. This Cancer Research UK model seeks novel agents from industry for  investigation by ECMC researchers with hypothesis driven combination proposals in cancer including cancers of high unmet need and radiotherapy combinations, areas not traditionally supported by industry. It is aligned with Cancer Research UK’s vision to bring forward the day when all cancers are cured.  

See open calls for proposals >


Need support in translating your early phase combination idea into a clinical trial? We can support you bring your early phase combination idea to clinic.


Keen to broaden your portfolio with novel combinations? We can connect you to an expert academic early phase network.

Useful Links